drugset / Trial / NCT05001204
68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor
NaSingle-groupOpen-labelDiagnostic
Summary
This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-RM26 in Gastrointestinal stromal tumor(GIST)patients. A single dose of 55.5 to 148 MBq(1.5-4 mCi) of 68Ga-NOTA-RM26 will be injected intravenously. Patients underwent whole-body PET/CT scans at 30-90 minutes after intravenous injection.
Timeline
- Start
- 2021-05-01
- Primary completion
- 2022-08-31
- Completion
- 2022-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-NOTA-RM26 | Diagnostic / imaging agent | 55.5 mbq | Intravenous |
| Subject | 68Ga-NOTA-RM26 | Diagnostic / imaging agent | 148 mbq | Intravenous |